AssetMark Inc
USNA icon

AssetMark Inc’s Usana Health Sciences USNA Stock Holding History

AssetMark Inc’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$161 – 2128
2023
Q4 		$161 Buy
+3
New +$152 ﹤0.01% 1790
2019
Q1 		– Sell
-11
Closed -$1K – 1514
2018
Q4 		$1K Hold
11
– – ﹤0.01% 1367
2018
Q3 		$1K Sell
11
-3
-21% -$372 ﹤0.01% 1369
2018
Q2 		$2K Hold
14
– – ﹤0.01% 1285
2018
Q1 		$1K Buy
14
+3
+27% +$232 ﹤0.01% 1362
2017
Q4 		$1K Buy
+11
New +$736 ﹤0.01% 1732

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AssetMark Inc's USNA Position: Q1 2024 in Review

AssetMark Inc sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 3 shares — an estimated $161 sold.

AssetMark Inc first reported a position in USNA in Q4 2017 and held it in 6 quarters. The position peaked at $2K in Q2 2018. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

  • AssetMark Inc reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
  • AssetMark Inc sold 3 Usana Health Sciences shares in Q1 2024, an estimated $161.
  • AssetMark Inc first reported a position in Usana Health Sciences in Q4 2017 and held it in 6 quarters.
  • AssetMark Inc's Usana Health Sciences position peaked at $2K in Q2 2018.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.